Intended for healthcare professionals

  1. Research
  2. The natural history of...
  3. The natural history of chronic airflow obstruction.
Research Article

The natural history of chronic airflow obstruction.

Br Med J 1977; 1 doi: https://doi.org/10.1136/bmj.1.6077.1645 (Published 25 June 1977) Cite this as: Br Med J 1977;1:1645

Related articles

  • No related articles found.

See more

Cited by...

  • COPD beyond proximal bronchial obstruction: phenotyping and related tools at the bedside
  • Heterogeneity in the respiratory symptoms of patients with mild-moderate COPD
  • Multiethnic meta-analysis identifies new loci for pulmonary function
  • Chronic Airway Diseases Early Stratification (CADSET): a new ERS Clinical Research Collaboration
  • Respiratory viral infection: a potential "missing link" in the pathogenesis of COPD
  • Relative and absolute lung function change in a general population aged 60-102 years
  • Women and COPD: do we need more evidence?
  • Real-world use of rescue inhaler sensors, electronic symptom questionnaires and physical activity monitors in COPD
  • COPD biomarkers and phenotypes: opportunities for better outcomes with precision imaging
  • Personalised pulmonary rehabilitation in COPD
  • AHRR hypomethylation, lung function, lung function decline and respiratory symptoms
  • COPD: time to improve its taxonomy?
  • Prevalence and burden of chronic bronchitis symptoms: results from the BOLD study
  • Natural history of COPD: gaps and opportunities
  • The effect of organic dust exposure on long-term change in lung function: a systematic review and meta-analysis
  • Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD score
  • Improved outcomes in ex-smokers with COPD: a UK primary care observational cohort study
  • Smoking cessation and COPD: further evidence is more necessary than ever
  • Inhaled resveratrol treatments slow ageing-related degenerative changes in mouse lung
  • Genetic variants affecting cross-sectional lung function in adults show little or no effect on longitudinal lung function decline
  • Formula one: best is no formula
  • Long-term change in reactance by forced oscillation technique correlates with FEV1 decline in moderate COPD patients
  • Chronic respiratory disease - the acceptable epidemic?
  • Persistence of circulating endothelial microparticles in COPD despite smoking cessation
  • The effect of smoking on lung function: a clinical study of adult-onset asthma
  • Individualized prediction of lung-function decline in chronic obstructive pulmonary disease
  • Predicting individual lung-function trajectories: An opportunity for prevention?
  • The Effect of Pulmonary Function Testing on the Success of Smoking Cessation
  • Natural experiments and large databases in respiratory and cardiovascular disease
  • Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity
  • Noninvasive quantification of alveolar morphometry in elderly never- and ex-smokers
  • The effect of occupational farming on lung function development in young adults: a 15-year follow-up study
  • Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit
  • Defining airflow limitation and chronic obstructive pulmonary disease: the role of outcome studies
  • Interaction between asthma and smoking increases the risk of adult airway obstruction
  • Inhaled corticosteroids in COPD: the clinical evidence
  • Ageing and the border between health and disease
  • A longitudinal study of lung function from 1 month to 18 years of age
  • Network medicine, multimorbidity and the lung in the elderly
  • The path to personalised medicine in COPD
  • The natural history of COPD: confirming and going beyond Fletcher and Peto
  • Disease progression in young patients with COPD: rethinking the Fletcher and Peto model
  • Tobacco use among designated air pollution victims and its association with lung function and respiratory symptoms: a retrospective cross-sectional study
  • Exacerbation frequency and FEV1 decline of COPD: is it geographic?
  • Longitudinal assessment in COPD patients: multidimensional variability and outcomes
  • Monitoring disease progression in COPD patients: one step beyond!
  • COPD prognosis in relation to diagnostic criteria for airflow obstruction in smokers
  • Neglected evidence in idiopathic pulmonary fibrosis: from history to earlier diagnosis
  • Alternative ways of expressing FEV1 and mortality in elderly people with and without COPD
  • Smoking cessation strategies in patients with COPD
  • The role of bronchodilator treatment in the prevention of exacerbations of COPD
  • Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality
  • The EvA study: aims and strategy
  • Is It Asthma, COPD, or Something In Between, and Does it Matter?
  • Four-year trial of tiotropium in chronic obstructive pulmonary disease
  • Chronic cough and sputum production: a clinical COPD phenotype?
  • The European Respiratory Society spirometry tent: a unique form of screening for airway obstruction
  • Total desmosines in plasma and urine correlate with lung function
  • Improving smoking cessation approaches at the individual level
  • Quality Assurance of the Pulmonary Function Technologist
  • Matrix metalloproteinase-12 (MMP-12) SNP affects MMP activity, lung macrophage infiltration and protects against emphysema in COPD
  • Impact of non-linear smoking effects on the identification of gene-by-smoking interactions in COPD genetics studies
  • Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study
  • CT-quantified emphysema in male heavy smokers: association with lung function decline
  • Effect of {beta} blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study
  • Tuberculosis Immunopathology: The Neglected Role of Extracellular Matrix Destruction
  • Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study
  • Short-term effect of changes in smoking behaviour on emphysema quantification by CT
  • Lung Diffusing Capacity in Adult Bronchiectasis: A Longitudinal Study
  • Chromosome 4q31 locus in COPD is also associated with lung cancer
  • Treatment of COPD: the sooner the better?
  • Mucus hypersecretion in COPD: should we only rely on symptoms?
  • Respiratory disease in 2010: looking to the past will prepare us for the future
  • Prevalence and underdiagnosis of chronic obstructive pulmonary disease among patients at risk in primary care
  • Calculating gambling odds and lung ages for smokers
  • Therapeutic implications of the pathophysiology of COPD
  • Is COPD in adulthood really so far removed from early development?
  • Is There a Role for Screening Spirometry?
  • Smoking cessation: the potential role of risk assessment tools as motivational triggers
  • Epidemiology of COPD
  • Pharmacological actions of statins: potential utility in COPD
  • Potential benefits of statins on morbidity and mortality in chronic obstructive pulmonary disease: a review of the evidence
Back to top